These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1073 related articles for article (PubMed ID: 29980607)

  • 21. Randomised clinical trial: Faecal microbiota transplantation for irritable bowel syndrome with diarrhoea.
    Yau YK; Su Q; Xu Z; Tang W; Ching JYL; Mak JWY; Cheung CP; Fung M; Ip M; Chan PKS; Wu JCY; Chan FKL; Ng SC
    Aliment Pharmacol Ther; 2023 Oct; 58(8):795-804. PubMed ID: 37667968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials.
    Wu J; Lv L; Wang C
    Front Cell Infect Microbiol; 2022; 12():827395. PubMed ID: 35295757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS).
    El-Salhy M; Hausken T; Hatlebakk JG
    Nutrients; 2019 Jun; 11(6):. PubMed ID: 31238507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in fecal short-chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome.
    El-Salhy M; Valeur J; Hausken T; Gunnar Hatlebakk J
    Neurogastroenterol Motil; 2021 Feb; 33(2):e13983. PubMed ID: 32945066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in colonic enteroendocrine cells of patients with irritable bowel syndrome following fecal microbiota transplantation.
    Mazzawi T; Hausken T; El-Salhy M
    Scand J Gastroenterol; 2022 Jul; 57(7):792-796. PubMed ID: 35156893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Open-Labeled Study on Fecal Microbiota Transfer in Irritable Bowel Syndrome Patients Reveals Improvement in Abdominal Pain Associated with the Relative Abundance of Akkermansia Muciniphila.
    Cruz-Aguliar RM; Wantia N; Clavel T; Vehreschild MJGT; Buch T; Bajbouj M; Haller D; Busch D; Schmid RM; Stein-Thoeringer CK
    Digestion; 2019; 100(2):127-138. PubMed ID: 30423561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protocol for faecal microbiota transplantation in irritable bowel syndrome: the MISCEAT study - a randomised, double-blind cross-over study using mixed microbiota from healthy donors.
    Hurych J; Vejmelka J; Hlinakova L; Kramna L; Larionov V; Kulich M; Cinek O; Kohout P
    BMJ Open; 2022 Jun; 12(6):e056594. PubMed ID: 35760542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fecal microbiota transplantation for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Wang M; Xie X; Zhao S; Ma X; Wang Z; Zhang Y
    Front Immunol; 2023; 14():1136343. PubMed ID: 37275867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Xu D; Chen VL; Steiner CA; Berinstein JA; Eswaran S; Waljee AK; Higgins PDR; Owyang C
    Am J Gastroenterol; 2019 Jul; 114(7):1043-1050. PubMed ID: 30908299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A meta-analysis of randomized controlled trials evaluating the effectiveness of fecal microbiota transplantation for patients with irritable bowel syndrome.
    Wang Y; Hu Y; Shi P
    BMC Gastroenterol; 2024 Jul; 24(1):217. PubMed ID: 38970007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors.
    Lin H; Guo Q; Wen Z; Tan S; Chen J; Lin L; Chen P; He J; Wen J; Chen Y
    Microb Cell Fact; 2021 Dec; 20(1):233. PubMed ID: 34963452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome are mirrored by changes in gut microbiome.
    Goll R; Johnsen PH; Hjerde E; Diab J; Valle PC; Hilpusch F; Cavanagh JP
    Gut Microbes; 2020 Nov; 12(1):1794263. PubMed ID: 32991818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal microbiota transplantation for managing irritable bowel syndrome.
    El-Salhy M; Mazzawi T
    Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):439-445. PubMed ID: 29493330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical efficacy and safety of faecal microbiota transplantation in the treatment of irritable bowel syndrome: a systematic review, meta-analysis and trial sequential analysis.
    Lo SW; Hung TH; Lin YT; Lee CS; Chen CY; Fang CJ; Lai PC
    Eur J Med Res; 2024 Sep; 29(1):464. PubMed ID: 39289768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study.
    Holster S; Lindqvist CM; Repsilber D; Salonen A; de Vos WM; König J; Brummer RJ
    Clin Transl Gastroenterol; 2019 Apr; 10(4):e00034. PubMed ID: 31009405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
    Mazzawi T; El-Salhy M; Lied GA; Hausken T
    Front Cell Infect Microbiol; 2021; 11():524851. PubMed ID: 34055657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlations between microbiota and metabolites after faecal microbiota transfer in irritable bowel syndrome.
    Holster S; Repsilber D; Geng D; Hyötyläinen T; Salonen A; Lindqvist CM; Rajan SK; de Vos WM; Brummer RJ; König J
    Benef Microbes; 2021 Feb; 12(1):17-30. PubMed ID: 33350360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fecal microbiota transplantation influences microbiota without connection to symptom relief in irritable bowel syndrome patients.
    Hartikainen AK; Jalanka J; Lahtinen P; Ponsero AJ; Mertsalmi T; Finnegan L; Crispie F; Cotter PD; Arkkila P; Satokari R
    NPJ Biofilms Microbiomes; 2024 Aug; 10(1):73. PubMed ID: 39191760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecal microbiota transfer for bowel disorders: efficacy or hype?
    Schmulson M; Bashashati M
    Curr Opin Pharmacol; 2018 Dec; 43():72-80. PubMed ID: 30218939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live
    Srivastava S; Basak U; Naghibi M; Vijayakumar V; Parihar R; Patel J; Jadon PS; Pandit A; Dargad RR; Khanna S; Kumar S; Day R
    Gut Microbes; 2024; 16(1):2338322. PubMed ID: 38630015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.